| 1 |
2022 |
Joud Alalwani, Sereen Eljazzar, Maya Basil, Reema Tayyem. The impact of health status, diet and lifestyle on non‐alcoholic fatty liver disease: Narrative review, Clinical Obesity. 2022; 12: e12525.
https://doi.org/10.1111/cob.12525 |
| 2 |
2023 |
Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, Michael Charlton. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance, Journal of Hepatology. 2023; 79: 1524.
https://doi.org/10.1016/j.jhep.2023.08.030 |
| 3 |
2023 |
Amedeo Lonardo, Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies, Exploration of Digestive Diseases. 2023; 188.
https://doi.org/10.37349/edd.2023.00026 |
| 4 |
2021 |
Amedeo Lonardo, Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?, Journal of Clinical Medicine. 2021; 10: 492.
https://doi.org/10.3390/jcm10030492 |
| 5 |
2020 |
Jessica Binetti, Laia Bertran, David Riesco, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jose Antonio Porras, Javier Camaron, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD, Life. 2020; 10: 245.
https://doi.org/10.3390/life10100245 |
| 6 |
2022 |
Hanzhang Wu, Xiaolu He, Qian Li, Yunliang Zheng, Sabina Rayamajhi, Amrish Thapa, Ge Meng, Qing Zhang, Li Liu, Hongmei Wu, Yeqing Gu, Shunming Zhang, Tingjing Zhang, Xuena Wang, Juanjuan Zhang, Zhixia Cao, Jun Dong, Xiaoxi Zheng, Xu Zhang, Xinrong Dong, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Hong Chang, Kaijun Niu. Relationship between the consumption of wholegrain and nonalcoholic fatty liver disease: The TCLSIH cohort study, Clinical Nutrition. 2022; 41: 1483.
https://doi.org/10.1016/j.clnu.2022.05.009 |
| 7 |
2023 |
Stefano Ballestri, Amedeo Lonardo. Ultrasonographic fatty liver indicator (US-FLI): a reliable biomarker for non-invasive NAFLD stratification, Metabolism and Target Organ Damage. 2023; 3:
https://doi.org/10.20517/mtod.2023.21 |
| 8 |
2020 |
Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Mariapia Vairetti, Andrea Ferrigno. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research, International Journal of Molecular Sciences. 2020; 21: 9646.
https://doi.org/10.3390/ijms21249646 |
| 9 |
2020 |
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver Disease, International Journal of Molecular Sciences. 2020; 21: 5888.
https://doi.org/10.3390/ijms21165888 |
| 10 |
2022 |
Amedeo Lonardo, Precision medicine in nonalcoholic fatty liver disease, Journal of Gastroenterology and Hepatology. 2022; 37: 1175.
https://doi.org/10.1111/jgh.15850 |
| 11 |
2022 |
Xiao-fei Tong, Qian-yi Wang, Xin-yan Zhao, Ya-meng Sun, Xiao-ning Wu, Li-ling Yang, Zheng-zhao Lu, Xiao-juan Ou, Ji-dong Jia, Hong You. Histological assessment based on liver biopsy: the value and challenges in NASH drug development, Acta Pharmacologica Sinica. 2022; 43: 1200.
https://doi.org/10.1038/s41401-022-00874-x |
| 12 |
2023 |
Donghee Kim, Brittany B. Dennis, George Cholankeril, Aijaz Ahmed. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis, Journal of Affective Disorders. 2023; 329: 184.
https://doi.org/10.1016/j.jad.2023.02.101 |
| 13 |
2023 |
Piero Portincasa, NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care, Internal and Emergency Medicine. 2023; 18: 993.
https://doi.org/10.1007/s11739-023-03203-0 |
| 14 |
2021 |
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management, Advances in Therapy. 2021; 38: 2130.
https://doi.org/10.1007/s12325-021-01690-1 |
| 15 |
2021 |
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease, Diagnostics. 2021; 11: 98.
https://doi.org/10.3390/diagnostics11010098 |
| 16 |
2021 |
Amedeo Lonardo, Separating the apples from the oranges: from NAFLD heterogeneity to personalized medicine, Exploration of Medicine. 2021;
https://doi.org/10.37349/emed.2021.00061 |
| 17 |
2022 |
Dante Romagnoli, Elimination of hepatitis C virus infection in Europe: targeting the obstacles, Exploration of Medicine. 2022; 71.
https://doi.org/10.37349/emed.2022.00075 |
| 18 |
2020 |
Óscar Soto-Angona, Gerard Anmella, María José Valdés-Florido, Nieves De Uribe-Viloria, Andre F. Carvalho, Brenda W. J. H. Penninx, Michael Berk. Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches, BMC Medicine. 2020; 18: 261.
https://doi.org/10.1186/s12916-020-01713-8 |
| 19 |
2023 |
Mirah Khalid Alshehhi, Asiya Nazir. 2023; 139.
https://doi.org/10.1016/B978-0-323-99336-4.00010-0 |
| 20 |
2023 |
Yongyuan He, Yinghong Su, Chengcheng Duan, Siyuan Wang, Wei He, Yingting Zhang, Xiaofei An, Ming He. Emerging role of aging in the progression of NAFLD to HCC, Ageing Research Reviews. 2023; 84: 101833101833.
https://doi.org/10.1016/j.arr.2022.101833 |
| 21 |
2023 |
Oana Petrea, Gabriela Stefanescu, Cristinel Stefanescu. 2023; 203.
https://doi.org/10.1007/978-3-031-33548-8_18 |
| 22 |
2023 |
Amedeo Lonardo, Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes, Exploration of Drug Science. 2023; 239.
https://doi.org/10.37349/eds.2023.00016 |
| 23 |
2023 |
Amedeo Lonardo, MASLD co-aggregates with HCC in families-names change, fa(c)ts remain, Hepatoma Research. 2023;
https://doi.org/10.20517/2394-5079.2023.110 |
